Researchers Leverage Insights from Patients with Long COVID or Myalgic Encephalomyelitis/Chronic Fatigue Syndrome to Improve Research and Development Efforts
In these examples, Solve-funded researchers leveraged patients’ lived experiences to guide research and development (R&D), ensuring projects addressed priorities most meaningful to patients and ultimately improving outcomes. The first describes how researchers utilized survey data to inform device design, while the other outlines the process of obtaining patient input early in the life cycle, which influenced the project’s direction.
Quick Facts Organization name: Solve ME |
Product Type(s)
medical device:
- home-use device
diagnostic product:
- other: symptom tracker
digital health technology:
- patient monitoring (sensors, etc.)
- digital diagnostic
Product Medical Specialty Area(s)
- other: infection-associated chronic conditions and illnesses
Stakeholders
- patients and caregivers, patient organizations
Methods and Sources of Patient Input
- patient advocacy organizations
- interviews/focus groups/surveys
- human-centered design methodologies
- patient-centered outcomes research
- patient-driven research agendas and investments
- patient-sensitive design controls
- patient burden of disease studies
- real-world data/evidence
Purpose of Patient Engagement
The purpose was to understand the research questions most important to patients. By engaging patients, both of the research teams could direct efforts to maximally benefit patients. For one of the projects, the researcher was able to use patient survey data from the Bateman Horne Center to develop a device that addressed the most meaningful symptoms experienced by patients.
Description of Patient Engagement Activities
One example used data on clinical experience from over 1,000 myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients from the Bateman Horne Center. The Center referred patients who could be most helpful in this project; then, the researcher corresponded with these patients via email to help design the device. Also, to better understand patients’ lived experiences, the research team mined survey data collected by the Center.
For the second example, patients regularly met with the research team to discuss new findings and to guide the study’s direction. Open forums were held to provide opportunities for people to provide input. Data were then collected and synthesized by researchers in the lab.
Impact of Patient Engagement
For the second example, patient engagement produced research papers about long COVID–associated symptoms of internal tremors and vibrations, as well as about symptoms sometimes experienced after receiving COVID-19 vaccines. This research is also important as it highlights the lived experience of people with long COVID, allowing researchers to target future efforts towards addressing these symptoms.
Lessons Learned
Engaging patients does not slow the research process; rather, over time, it saves time by more efficiently producing outcomes and products that are relevant and responsive to patient needs. Because long COVID and ME/CFS are diseases with myriad, heterogeneous symptoms, understanding the lived experiences of these patients helps researchers focus on the areas most likely to benefit patients and/or develop devices and therapeutics that target the most problematic symptoms.